| Literature DB >> 1362084 |
R Nishimura1, H Kim, S Matsunaga, M Sakaguchi, N Sasaki, H Tamura, A Takeuchi.
Abstract
The efficacy of atipamezole as a medetomidine antagonist was evaluated in pigs. The atipamezole doses (intramuscularly) were 80, 160, 320 and 480 micrograms/kg of body weight, which were one, two, four and six times higher than the preceding medetomidine dose (80 micrograms/kg, intramuscularly). Atipamezole effectively reversed medetomidine-induced sedation, and the optimal action was seen at doses of 160 and 320 micrograms/kg. Recovery from sedation was quick and smooth, and adverse effects such as hyperactivity or tachycardia were minimal with either dose.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1362084 DOI: 10.1292/jvms.54.1237
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267